These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 20703212
1. New paradigms in cell death in human diabetic nephropathy. Sanchez-Niño MD, Benito-Martin A, Ortiz A. Kidney Int; 2010 Oct; 78(8):737-44. PubMed ID: 20703212 [Abstract] [Full Text] [Related]
2. [Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy]. Benito-Martín A, Ucero AC, Santamaría B, Lorz C, Kretzler M, Rastaldi MP, Sánchez-Niño MD, Sanz A, Izquierdo MC, Ruiz Ortega M, Egido J, Ortiz A. Nefrologia; 2009 Oct; 29(1):13-9. PubMed ID: 19240767 [Abstract] [Full Text] [Related]
3. The MIF receptor CD74 in diabetic podocyte injury. Sanchez-Niño MD, Sanz AB, Ihalmo P, Lassila M, Holthofer H, Mezzano S, Aros C, Groop PH, Saleem MA, Mathieson PW, Langham R, Kretzler M, Nair V, Lemley KV, Nelson RG, Mervaala E, Mattinzoli D, Rastaldi MP, Ruiz-Ortega M, Martin-Ventura JL, Egido J, Ortiz A. J Am Soc Nephrol; 2009 Feb; 20(2):353-62. PubMed ID: 18842989 [Abstract] [Full Text] [Related]
4. BASP1 promotes apoptosis in diabetic nephropathy. Sanchez-Niño MD, Sanz AB, Lorz C, Gnirke A, Rastaldi MP, Nair V, Egido J, Ruiz-Ortega M, Kretzler M, Ortiz A. J Am Soc Nephrol; 2010 Apr; 21(4):610-21. PubMed ID: 20110383 [Abstract] [Full Text] [Related]
5. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD. Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883 [Abstract] [Full Text] [Related]
8. The death ligand TRAIL in diabetic nephropathy. Lorz C, Benito-Martín A, Boucherot A, Ucero AC, Rastaldi MP, Henger A, Armelloni S, Santamaría B, Berthier CC, Kretzler M, Egido J, Ortiz A. J Am Soc Nephrol; 2008 May; 19(5):904-14. PubMed ID: 18287563 [Abstract] [Full Text] [Related]
9. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. Chang YH, Lin KD, He SR, Hsieh MC, Hsiao JY, Shin SJ. Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686 [Abstract] [Full Text] [Related]
10. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH. Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875 [Abstract] [Full Text] [Related]
11. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy. Yao F, Li Z, Ehara T, Yang L, Wang D, Feng L, Zhang Y, Wang K, Shi Y, Duan H, Zhang L. Mol Cell Endocrinol; 2015 Aug 15; 411():232-42. PubMed ID: 25958041 [Abstract] [Full Text] [Related]
12. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
13. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM. Int J Cancer; 2002 Jun 01; 99(4):491-504. PubMed ID: 11992538 [Abstract] [Full Text] [Related]
14. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines. van Geelen CM, de Vries EG, Le TK, van Weeghel RP, de Jong S. Br J Cancer; 2003 Jul 21; 89(2):363-73. PubMed ID: 12865931 [Abstract] [Full Text] [Related]
15. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Sun SY, Yue P, Lotan R. Oncogene; 2000 Sep 14; 19(39):4513-22. PubMed ID: 11002424 [Abstract] [Full Text] [Related]
16. Immunohistochemical Aspects of Cell Death in Diabetic Nephropathy. Bălăşescu E, Cioplea M, Brînzea A, Nedelcu R, Zurac S, Ion DA. Rom J Intern Med; 2016 Sep 14; 54(1):54-62. PubMed ID: 27141571 [Abstract] [Full Text] [Related]
17. Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings. Baba K, Minatoguchi S, Sano H, Kagawa T, Murata I, Takemura G, Hirano T, Ohashi H, Takemura M, Fujiwara T, Fujiwara H. Nephrology (Carlton); 2004 Apr 14; 9(2):94-9. PubMed ID: 15056269 [Abstract] [Full Text] [Related]
18. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Chopin V, Slomianny C, Hondermarck H, Le Bourhis X. Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702 [Abstract] [Full Text] [Related]
19. Thyrocyte targets and effectors of autoimmunity: a role for death receptors? Hammond LJ, Palazzo FF, Shattock M, Goode AW, Mirakian R. Thyroid; 2001 Oct 15; 11(10):919-27. PubMed ID: 11716038 [Abstract] [Full Text] [Related]
20. CD95 (FAS) and CD178 (FASL) induce the apoptosis of CD4+ and CD8+ cells isolated from the peripheral blood and spleen of dogs naturally infected with Leishmania spp. Silva KL, Melo LM, Perosso J, Oliveira BB, Santos PS, Eugênio Fde R, Lima VM. Vet Parasitol; 2013 Nov 08; 197(3-4):470-6. PubMed ID: 23920055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]